MedPath

Confirmation of improvement effects on skin function by inhalation of citrus oil-inducing odorant

Not Applicable
Conditions
Healthy female adults
Registration Number
JPRN-UMIN000049200
Lead Sponsor
CPCC Company Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Subjects who take steadily (not less than three times a week) in the health-specific/functional/supplementary (e.g., gamma-aminobutyric acid, glucosylceramide, sodium hyaluronate, L-theanine)/health foods, which might affect the test results. (2) Subjects who have taken affecting medicines (e.g., skin roughness-improving drug, and sleeping pill), and have any difficulty in refraining from taking them during this trial. (3) Subjects with the condition of being over-sensitiveness to cold, even during the summer season. (4) Subjects who realized that the subjects themselves must be in a state of menopausal symptom. (5) Subjects with nasal congestion and/or wrong judgement of fragrance. (6) Subjects falling into the habit of smoking within one year before this trial. (7) Subjects having a bruise and/or a hurt near the skin-measuring position (left cheek part). (8) Subjects having their skin roughness due to pollinosis, during this trial. (9) Subjects with excessive suntan, and/or some kind of work/sport outside for a long time. (10) Subjects who are possible to go on a trip, and/or a business one during this trial, which might affect the test-device usage. (11) Subjects who are now under a specific facial care (e.g., facial/body treatment, electric facial, peeling, laser therapy, and hair removal) at an outside agency. (12) Subjects who have previous/current medical history of severe cardiac, hepatic, renal or digestive diseases. (13) Pregnant, lactating women, or possibly pregnant ones. (14) Subjects suffering from atopic/contact dermatitis, and skin hypersensitivity. (15) Subjects who are now under other clinical tests with some kind of medicine and/or health food, or partook in those within four weeks before this trial, or are planning to participate in those after giving informed consent to take part in this trial. (16) Others who have been determined as ineligible for participation, judging from the investigator's opinions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath